270 results on '"Fanella, Martina"'
Search Results
2. Salivary α‐Synuclein as a Candidate Biomarker of Parkinsonism in 22q11.2 Deletion Syndrome
3. Olfactory impairment in autoimmune encephalitis: another piece of the puzzle
4. Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
5. High rates of early remission pattern in adult-onset compared with earlier-onset idiopathic generalized epilepsy: A long-term follow-up study
6. Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)
7. Effect of the COVID-19 pandemic and the lockdown measures on the local stroke network
8. Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
9. An uncommon case of thunderclap headache in a patient with Marfan syndrome
10. Seizures in autoimmune encephalitis: Findings from an EEG pooled analysis
11. Non-convulsive status epilepticus versus periodic EEG pattern in sporadic Creutzfeldt-Jakob disease: two sides of the same coin?
12. Progressive Myoclonus Epilepsies: Diagnostic Yield With Next-Generation Sequencing in Previously Unsolved Cases
13. Musicogenic epilepsy in paraneoplastic limbic encephalitis: a video‐EEG case report
14. Perampanel as adjunctive therapy in highly refractory epilepsies: Real-world data from an Italian tertiary care epilepsy centre
15. Epileptic seizures heralding a relapse in high grade gliomas
16. Social cognition and real‐life functioning in patient samples with 22q11.2 deletion syndrome with or without psychosis, compared to a large sample of patients with schizophrenia only and healthy controls
17. Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy.
18. Progressive myoclonus epilepsies due to SEMA6B mutations. New variants and appraisal of published phenotypes
19. Structural Cerebellar Abnormalities and Parkinsonism in Patients with 22q11.2 Deletion Syndrome
20. Late-onset seizures and epilepsy: Electroclinical features suggestive of autoimmune etiology
21. Switch From Originator to Equivalent Drug in the Era of Generic Antiepileptic Drugs: Study of Keppra Versus Epitiram Clinical Equivalence
22. Variable course of Unverricht-Lundborg disease: Early prognostic factors
23. Ictal epileptic headache revealing non convulsive status epilepticus in a case of eyelid myoclonia with absences
24. Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST)
25. The Relationship between Motor Symptoms, Signs, and Parkinsonism with Facial Emotion Recognition Deficits in Individuals with 22q11.2 Deletion Syndrome at High Genetic Risk for Psychosis.
26. Recognition of facial emotion expressions and perceptual processes in 22q11.2 deletion syndrome.
27. Recognition of facial emotion expressions and perceptual processes in 22q11.2 deletion syndrome
28. Generalized Fast Discharges Along the Genetic Generalized Epilepsy Spectrum: Clinical and Prognostic Significance
29. Olfactory impairment in autoimmune encephalitis: A possible clinical clue?
30. Seizure outcome trajectories in a well‐defined cohort of newly diagnosed juvenile myoclonic epilepsy patients
31. The grey zone between autoimmune encephalitis and autoimmune‐associated epilepsy
32. Progressive Myoclonus Epilepsies
33. Social Cognition Impairments in 22q11.2DS Individuals With and Without Psychosis: A Comparison Study With a Large Population of Patients With Schizophrenia
34. Musicogenic epilepsy in paraneoplastic limbic encephalitis: a video-EEG case report
35. Unilateral catalepsy in non‐convulsive status epilepticus
36. Neuropsychiatric features and genetic aspects in 22q11.2 deletion syndrome
37. Molecular Chaperones and miRNAs in Epilepsy: Pathogenic Implications and Therapeutic Prospects
38. Functional Gastrointestinal Disorders in Patients With Epilepsy: Reciprocal Influence and Impact on Seizure Occurrence
39. Reconsidering the role of selective sodium channel blockers in genetic generalized epilepsy
40. Evolution of EEG patterns in cerebral reperfusion syndrome after carotid artery stenting
41. Oxcarbazepine-induced myoclonic status epilepticus in juvenile myoclonic epilepsy
42. Clozapine‐induced gastroesophageal rumination in 22q11.2 Deletion Syndrome. A case report on gastroesophageal side effects management without renouncing clozapine's effectiveness
43. Valproate impact and sex-dependent seizure remission in patients with idiopathic generalized epilepsy
44. Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures.
45. Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective
46. Idiopathic generalized epilepsy and café-au-lait macules as the predominant features in NF1 mild form
47. The spectrum of epileptic syndromes with fixation off sensitivity persisting in adult life
48. Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects
49. Cannabinoids in the treatment of epilepsy: Current status and future prospects
50. An Italian multicentre study of perampanel in progressive myoclonus epilepsies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.